for prophylaxis of ischemic complications of unstable angina and non-Q-wave myocardial infarction or when administered (in conjunction with warfarin) as inpatient treatment of acute DVT with or ...

Purpose: The current indications, dosing, and practical considerations for use of newer anticoagulants in patients with various degrees of renal impairment who do not require dialysis are reviewed.

Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...

The timing of restarting oral anticoagulation (OAC) for patients with atrial fibrillation (AF) after experiencing an acute ...

such as the direct oral anticoagulants, but also because of the development of new clinical and therapeutic indications, which go beyond the classical prevention of cardioembolism in atrial ...

"Associations between dose of anticoagulation and outcome appeared broadly consistent across all predefined patient subgroups ...

US biotech Regeneron Pharmaceuticals has announced positive Phase II results for two novel monoclonal antibodies targeting ...

Dan Bloomfield, MD, chief medical officer, Anthos, walks through promising findings demonstrating the efficacy of abelacimab, ...

FRIDAY, Dec. 6, 2024 (HealthDay News) -- Noninferiority of reduced- versus full-dose anticoagulants cannot be proven in ...

Anticoagulation with apixaban or rivaroxaban may be used to reduce thromboembolism risk, but be wary of fracture risk.